Some of Griffith University’s most outstanding research students have been acknowledged at the Institute for Glycomics Student Scholarships Awards evening. Awards from the following schemes were presented at the event: 2020/2021 Summer Scholarships 2021 Glycomics Student Scholarships 2020/2021 Summer Scholarships The 2020/2021 Summer Scholarships scheme is proudly supported by Community Bank of Paradise Point, Bendigo […]
For the entire month of May, and highlighting Mother’s Day, Griffith University’s Institute for Glycomics is partnering with local Gold Coast florists to raise funds and awareness to support vital research into cancers that affect women. “The Mum’s the Word Mother’s Day campaign invites the local community to ‘thank her a bunch’ by gifting the […]
Griffith University’s Institute for Glycomics has been awarded $2.66 million in Ideas Grant funding from the National Health and Medical Research Council (NHMRC) to aid four vital research projects. Director Professor Mark von Itzstein AO was delighted with the grant awards and said they cemented the Institute’s reputation as a leading biomedical research institute. “Our […]
A new experimental drug to treat sepsis has now entered the next stage of clinical trials in patients in Australia after successfully completing Phase 1a trials in healthy volunteers, reports Griffith University’s Institute for Glycomics. The sepsis drug candidate, co-invented by researchers led by Professor Mark von Itzstein AO at the Institute for Glycomics and […]
Dr Lara Herrero, research leader at Griffith University’s Institute for Glycomics, has been honoured with the Creating Change Award at the 2020 Gold Coast Women in Business Awards. The highly prestigious Women in Business Awards of Australia recognises and honours exceptional businesswomen and industry achievers who are making a difference across Queensland. “I am both […]
An experimental Alzheimer's disease treatment is proving effective at treating some of the most persistent, life-threatening antibiotic-resistant bacteria.
Griffith University researchers have discovered a novel approach that could lead to the personalised design of anticancer drugs that resist metastasis (tumour spread) in triple-negative breast cancer. Traditional chemotherapy includes metal-based drugs like Cisplatin, commonly used to treat breast and ovarian cancers. However, many of these traditional chemotherapies have severe side effects and cancers treated […]